Cohn J N
Am J Med. 1984 Aug 20;77(2A):67-70. doi: 10.1016/s0002-9343(84)80060-1.
Depressed contractile performance of the heart in congestive heart failure is aggravated by increases in preload and afterload related in part to arterial and venous constriction. Vasodilator drugs have a salutary effect on left ventricular performance by reducing aortic impedance and/or increasing venous capacitance resulting in an increase in stroke volume and a lowering of filling pressure. Vasodilators may act by counteracting the heightened neurohumoral vasoconstriction tone in heart failure (inhibition of the sympathetic nervous system, inhibition of the renin-angiotensin system) or by more directly affecting vascular smooth muscle tone (direct vasodilators, calcium antagonists). The immediate effects of these drugs on resting hemodynamics must be supplemented by knowledge of their effects on the circulatory response to exercise and of their efficacy during long-term administration before a rational choice can be made as to the ideal agent or combination of agents to use in the long-term management of congestive heart failure.
充血性心力衰竭时,心脏收缩功能降低,部分原因是动脉和静脉收缩导致前负荷和后负荷增加,从而使病情加重。血管扩张剂可通过降低主动脉阻抗和/或增加静脉容量,对左心室功能产生有益影响,进而增加心输出量并降低充盈压。血管扩张剂的作用机制可能是抵消心力衰竭时增强的神经体液血管收缩张力(抑制交感神经系统、抑制肾素-血管紧张素系统),或者更直接地影响血管平滑肌张力(直接血管扩张剂、钙拮抗剂)。在合理选择用于充血性心力衰竭长期治疗的理想药物或药物组合之前,必须了解这些药物对静息血流动力学的即时影响,并补充其对运动时循环反应的影响以及长期给药疗效的相关知识。